Use the Back button in your browser to see the other results of your search or to select another record.
| Improvement in quality of life with pelvic floor muscle training and biofeedback in patients with painful bladder syndrome/interstitial cystitis |
| Borrego-Jimenez P-S, Flores-Fraile J, Padilla-Fernandez B-Y, Valverde-Martinez S, Gomez-Prieto A, Marquez-Sanchez MT, Miron-Canelo J-A, Lorenzo-Gomez M-F |
| Journal of Clinical Medicine 2021 Feb;10(4):862 |
| clinical trial |
| 5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
OBJECTIVE: To prove the benefits of pelvic floor muscle training with biofeedback (BFB) as a complementary treatment in women with bladder pain syndrome/interstitial cystitis (BPS/IC). METHOD(S): Prospective, randomized study in 123 women with BPS/IC. Groups: BFB+ (n = 48): women with oral drug treatment (perphenazine and amitriptyline) plus intravesical instillations (sodium hyaluronate) plus pelvic floor muscle training with BFB; BFB- (n = 75): women with oral drug treatment plus intravesical instillations. Variables: age, body mass index (BMI), time of follow-up, length of disease, time free of disease, diseases and health conditions concomitant, and responses to the SF-36 health-related quality of life questionnaire at the first consultation (SF-36 pre-treatment), and at the end of the study (SF-36 post-treatment). The treatment was considered successful when the SF-36 score reached values equal to or greater than 80 points or when the initial value increased by 30 or more points. RESULT(S): Mean age was 51.62 years old (23 to 82). BMI was higher in BFB-. The mean length of BPS/IC condition was 4.92 years (1 to 20), shorter in BFB+ than in BFB-. Mean SF-36 score pre-treatment was 45.92 points (40 to 58), lower in BFB+ than in BFB-. Post-treatment SF-36 score was higher than pre-treatment SF-36 score both in BFB+ and BFB-. SF-36 values were higher in BFB+ compared to BFB- over the follow-up. CONCLUSION(S): BFB improves quality of life in women with BPS/IC as adjunct therapy to combined oral and intravesical treatment.
|